Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The researchers’ analysis found anxiety was the reason given for 16% of medicinal cannabis prescriptions. Queensland was the source of 51% of prescriptions between 2016 and 2021.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Project CBD

JANUARY 24, 2019

Some recent highlights and curiosities from the amazing world of cannabis science and therapeutics: CBD and autism. In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Cannabis and ADHD.

Research and Development 252

Research and Development Chronic Pain Cannabinoids Treatment 252

Peninsula Alternative Health

MARCH 1, 2018

Advocating for medical cannabis is no easy feat, and these organizations are spearheading state, national, and global efforts. The common mission of these nonprofits and trade associations is to educate on the benefits of medical cannabis and create legislative change for businesses, physicians, and qualifying patients.

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

Advocating for medical cannabis is no easy feat, and these organizations are spearheading state, national, and global efforts. The common mission of these nonprofits and trade associations is to educate on the benefits of medical cannabis and create legislative change for businesses, physicians, and qualifying patients.

Treatment 40

Treatment Education Advocacy Access 40

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

The Joint Blog

JANUARY 25, 2021

According to new research marijuana use is directly associated with a decrease in alcohol consumption among those seeking alcohol treatment. times less likely to have a binge-drinking episode on days that cannabis was used compared with days cannabis was not used”, states the study. 18%-39%, p< 001) and were 2.06

Treatment 26

Treatment Consumption Marijuana Data 26

Healer

MARCH 26, 2021

A growing number of studies are showing that cannabis is helping opioid users reduce their usage or stop completely. Additional resources on cannabis and opioids: Published data on cannabis treatment to reduce opioid usage. Dr. Sulak’s Cannabis and Opioid Guide. Play video.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

A growing number of studies are showing that cannabis is helping opioid users reduce their usage or stop completely. Additional resources on cannabis and opioids: Published data on cannabis treatment to reduce opioid usage. Dr. Sulak’s Cannabis and Opioid Guide. Play video.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

A growing number of studies are showing that cannabis is helping opioid users reduce their usage or stop completely. Additional resources on cannabis and opioids: Published data on cannabis treatment to reduce opioid usage. Dr. Sulak’s Cannabis and Opioid Guide. Play video.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

Some researchers believe cannabis can help wean prescription opioid users off the addictive and potentially deadly drugs. Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

CannaMD

NOVEMBER 22, 2020

Unfortunately, most traditional pharmaceutical options are distinctly lacking due to side effects, as well as a bit of trepidation (although Botox, one current treatment option for migraines, has gained popularity). The authors concluded: Inhaled cannabis reduces self-reported headache severity by 47.3% and migraine severity by 49.6%.

Marijuana 116

Marijuana Treatment Patients Cannabinoids 116

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. As the crisis rages on, modern experts are calling for a serious intervention—an intervention like legal cannabis. Interestingly, although opioids work well for acute pain (e.g.,

Programs 52

Programs Chronic Pain Treatment Conditions 52

Canna Law Blog

DECEMBER 21, 2023

Welcome to the eighth annual “State of the State” post on Oregon cannabis. Sales fell (again) along with licensee numbers (for the first time) According to OLCC data , retail sales between January 1, 2023 and November 30, 2023 clocked in at $874 million. By my math, the state is on pace for roughly $953 million this year.

Hemp 85

Hemp Retail Compliance Compliance 85

Cannabis Law Report

JANUARY 9, 2022

Legalizing cannabis for adults has been a wise investment. billion in tax revenue from legal, adult-use cannabis sales. billion in tax revenue from legal, adult-use cannabis sales. This document reviews each state’s adult-use cannabis tax structure, population, and revenue from legalization. Here’s what they say.

Collective 52

Collective Policy Retail Programs 52

PrestoDoctor

SEPTEMBER 6, 2023

The legalization of cannabis in some countries and states has brought about significant changes in the healthcare industry. However, with the increasing popularity of cannabis, many people are turning to marijuana as a safer and better alternative for pain management.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

CannaMD

DECEMBER 8, 2020

You might think that cannabis legalization would lead to a significant decrease in marijuana-related arrests, but that hasn’t been the case. Between 2016-2018, despite rapidly expanding state legalization, there was a slight increase in marijuana-related arrests year over year. MARIJUANA ARRESTS DECLINE FOR FIRST TIME SINCE 2015.

Marijuana 105

Marijuana Chronic Pain Treatment Legalization 105

Cannabis Law Report

FEBRUARY 15, 2022

The goal is to use the data for comparative analysis over time to help shape state policy. The goal is to use the data for comparative analysis over time to help shape state policy. NJSPL-Cannabis-Feb2022. The argument we are making is that graduation rates could change based on cannabis use,” said Menifield. “If

Policy 52

Policy Marijuana Data Education 52

Cannabis Law Report

MARCH 17, 2022

The national consumption of methylamphetamine, cocaine, MDMA and heroin increased year on year in the first four years of the Program (2016-17 to 2019-20), followed by a marked reduction in total consumption in year five (2020-21). The latest report presents data on Australia’s drug consumption for 12 substances. million Australians.

Consumption 52

Consumption Programs Data Treatment 52

Cannabis Law Report

FEBRUARY 17, 2020

PUBLISHER: CANNABIS LAW REPORT. Clearing the Air- Florida Condensed Cannabis . CANNABIS PRIMER. I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate. AUTHOR: Heather Allman. Americans for Safe Access.org. Kim Rivers; 2.Barry

Dispensary 76

Dispensary Patients Agriculture Conditions 76

The Cannigma

JUNE 30, 2021

On July 1st, 2021, new cannabis legalization are going into effect in Connecticut, New Mexico, and Virginia, just a couple days after a recreational cannabis legalization measure went into effect in South Dakota. Nearly half of all Americans now live in states where cannabis is legal for adult use. Spasms 4,937 21.9%

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

Cannabis Chronicles

APRIL 3, 2019

Although Washington voters legalized cannabis in 2012, Clark County passed a ban on recreational cannabis businesses in the unincorporated areas two years later. I think the data is too new,” responded Schoening. For instance, Main Street Marijuana in Vancouver generated 128 calls for service since 2016. Sheriff’s Cmdr.

Marijuana 100

Marijuana Data Recreational Topical 100

Canabo Medical Clinic

NOVEMBER 29, 2018

Medical cannabis has been suggested as one potential solution, especially as more research supports cannabis as an effective painkiller. Some studies suggest those using opioid medications can even reduce or eliminate their dependence on these substances by introducing medical marijuana to their treatment plans.

Patients 40

Patients Data Conditions Cannabis 40

Cannabis Law Report

NOVEMBER 14, 2019

Australia’s westernmost state is making it easier for patients to access medical cannabis. Western Australia cuts red tape for medical cannabis in boost for patients, industry. Rules relaxed as WA GPs get go-ahead to prescribe medical cannabis. Here’s the MJ Biz report. This is what WA Today said earlier this week.

Patients 45

Patients Access Medicine Pharmaceutical 45

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] For the regulated community, this is a trend worth watching. Defining Psychedelics. 2] David E. 264, 266 (Apr. 4] Jennifer M.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 24, 2022

The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 billion by 2029.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Veriheal

JULY 5, 2021

Cannabis is brimming with hundreds of active cannabinoids, but just two have really managed to steal the limelight – THC (tetrahydrocannabinol) and CBD (cannabidiol). In spite of their fairly equal dominance in the legal cannabis space—collectively, these cannabinoids racked up $17.5 billion in legal U.S. billion in legal U.S.

THC 52

THC CBD Treatment Cannabinoids 52

CannaMD

NOVEMBER 6, 2019

Using Cannabis to Quit Opioids. The authors report that the legalization of medical marijuana: May be effective at reducing opioid reliance as survey respondents living in states with medical cannabis legislation are much less apt to report using opioid analgesics than people living in states without such laws, net other factors.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Qualified patient.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

NOVEMBER 18, 2019

And in a sign of the times, a newly formed Cannabis Section of the Bar held its first meet-and-greet event Thursday evening — just a few years after a proposal for a similar marijuana lawyer-focused group was denied. . We have sent some attorneys through our diversion program for professional substance abuse treatment.

Dispensary 49

Dispensary Recreational Cannabis Marijuana 49

Freedom Leaf

JANUARY 4, 2018

“Our goal is to bring awareness of emerging innovation and opportunities to the East Coast regarding cannabis technology.” Cofounder, Jade Insights and Cannabis Tech Group, New York, N.Y. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making.

Data 60

Data Policy Media Cannabis 60

Cannabis Law Report

JANUARY 6, 2022

Mental health treatment is big business, with the global antidepressant drug market valued at over $13 billion in 2016. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. Insurance won’t cover treatment sessions due to psilocybin’s status as a Schedule I drug.

Access 52

Access Patients Research and Development Treatment 52

The Joint Blog

OCTOBER 6, 2019

For the study, researchers analyzed approximately 800,000 urine drug test results collected from pain management patients between the years 2016 and 2018. Further studies are also needed to determine if THC/cannabis use alone or in combination with other medical treatments may help combat OUD (opioid use disorder).”

Concentrates 48

Concentrates Patients THC Collective 48

Cannabis Law Report

JUNE 8, 2022

MDMA-assisted therapy, a novel treatment for PTSD with FDA breakthrough therapy designation, is on track for NDA submission in 2023 pending results of the confirmatory Phase 3 trial. He previously served as the global CEO for both Sandoz and Alcon, at Novartis Group, where he served on the Executive Committee from 2008 to 2016.

Therapy 52

Therapy Treatment Access Patients 52

CannaMD

JUNE 18, 2020

There’s no debate that strains of certain cannabis which create a high have well-known and documented effects on short-term memory and motor function. Less certain are the potential long-term effects of cannabis consumption on cognitive function. But does marijuana really make you less intelligent?

Research and Development 80

Research and Development Marijuana Education Treatment 80

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). The procedure for sourcing cannabis from an authorized producer is relatively simple. The Canadian Medical Association (CMA).

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

JUNE 26, 2019

Minister for Health Simon Harris TD today signed legislation which will allow for the operation of the Medical Cannabis Access Programme on a pilot basis for five years. The Programme will facilitate access to cannabis-based products for medical use in line with legislation. We have highlighted relevant passages.

Medicine 55

Medicine Access Business Legislation 55

Veriheal

MAY 14, 2021

A 2021 study found that cannabis is not associated with changes in the brains’ morphology and that these changes are rather caused by alcohol consumption. Cannabis Was Originally Thought to Negatively Impact Brain Structure. A 2016 study took to understanding “adolescent cortical thickness pre-and-post marijuana’.

Research and Development 52

Research and Development Consumption Cannabis Data 52